CML management recommendations (Baccarani et al., J Clin Oncol 2009;27:6041-51) among the 50 top cited papers of JCO 2009.
The ELN recommendations for CML are now available in Japanese language. The booklet can be ordered directly from ELIC.
ELN Frontiers is an annual educational program of the EUTOS (European Treatment and Outcome Study for CML) project, a collaboration between the European LeukemiaNet and Novartis Oncology Europe. Abstracts of the meeting in Berlin are available online now.
The CT-directive 2001/20/EC (directive on clinical trials) could be adopted around 10/2011. The process is leaded by DG Sanco at the EC and described in the Roadmap (“action plan”). One element of the action plan has been the process of the public consultation of the paper "Assessment of the functioning of the 'Clinical Trials Directive' 2001/20/EC". The ELN has been one of about 100 contributors to this paper.
The ELN Foundation is a non-profit charitable organisation, which supports the goals of the European LeukemiaNet to foster science and research and to improve and enhance medical care in acute and chronic leukaemia and related disease entities.
The EUTOS for CML Registry will collect baseline, treatment and outcome data on patients with CML in Europe by implementing and enlarging the current European CML Registry. The Online access to the EUTOS – eCRF – System and the CRF paper version are available at the EUTOS website.
